Correction, Dept. of - As enacted, authorizes the department to adopt or amend a formulary for use in the correctional facilities operated by or on behalf of the department. - Amends TCA Title 8; Title 41; Title 53; Title 56; Title 63; Title 68 and Title 71.

SB 1790 requires insurers covering inmates in Tennessee to treat FDA-approved non-opioid pain medications equally with opioids in their preferred drug lists (PDLs), meaning non-opioid options cannot be disadvantaged in coverage or cost-sharing. It directly affects insurers offering policies that cover incarcerated individuals, including TennCare and private health plans. The law mandates that non-opioid medications (approved by the FDA for pain management) must have equal coverage treatment relative to opioids on the PDL, without prohibiting insurers from favoring one opioid over another. The bill applies to all such medications approved by the FDA for nine months or longer and takes effect January 1, 2027.